Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-12-022639
Filing Date
2012-03-30
Accepted
2012-03-30 10:04:07
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a12-3876_110k.htm 10-K 2588106
2 EX-21 a12-3876_1ex21.htm EX-21 1148
3 EX-23 a12-3876_1ex23.htm EX-23 2715
4 EX-31.1 a12-3876_1ex31d1.htm EX-31.1 9897
5 EX-31.2 a12-3876_1ex31d2.htm EX-31.2 9956
6 EX-32.1 a12-3876_1ex32d1.htm EX-32.1 4615
7 EX-32.2 a12-3876_1ex32d2.htm EX-32.2 4576
  Complete submission text file 0001104659-12-022639.txt   7853044

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT clsp-20111231.xml EX-101.INS 1105314
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsp-20111231.xsd EX-101.SCH 31276
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsp-20111231_cal.xml EX-101.CAL 90498
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsp-20111231_def.xml EX-101.DEF 147793
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT clsp-20111231_lab.xml EX-101.LAB 444519
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsp-20111231_pre.xml EX-101.PRE 188753
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 12726439
SIC: 2834 Pharmaceutical Preparations